Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


21.08.2018

1 Am J Pathol
3 Ann Surg Oncol
2 BMC Cancer
1 Br J Cancer
2 Br J Dermatol
1 Cancer Res
1 Eur J Dermatol
3 Int J Cancer
2 J Surg Oncol
2 Lancet Oncol
4 Melanoma Res
2 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. CARON JM, Han X, Contois L, Vary CPH, et al
    The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism.
    Am J Pathol. 2018 Aug 14. pii: S0002-9440(18)30253.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. KROON HM, van der Bol WD, Tonks KT, Hong AM, et al
    Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities.
    Ann Surg Oncol. 2018 Aug 16. pii: 10.1245/s10434-018-6692.
    PubMed     Text format     Abstract available

  3. GERSHENWALD JE, Scolyer RA
    Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6689.
    PubMed     Text format     Abstract available

  4. LEONG SP, Wu M, Lu Y, Torre DM, et al
    Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6685.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. DEPCZYNSKI J, Dobbins T, Armstrong B, Lower T, et al
    Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.
    BMC Cancer. 2018;18:33.
    PubMed     Text format     Abstract available

  6. KUCHERLAPATI M
    Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
    BMC Cancer. 2018;18:818.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. KRISP C, Parker R, Pascovici D, Hayward NK, et al
    Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis.
    Br J Cancer. 2018 Aug 17. pii: 10.1038/s41416-018-0227.
    PubMed     Text format     Abstract available


    Br J Dermatol

  8. CUST AE, Aitken J, Baade P, Whiteman D, et al
    Why a randomised melanoma screening trial may be a good idea.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17089.
    PubMed     Text format     Abstract available

  9. TSAI S, Scott JF, Keller JJ, Gerstenblith MR, et al
    Cutaneous malignancies identified on an inpatient Dermatology consult service.
    Br J Dermatol. 2017 Feb 23. doi: 10.1111/bjd.15401.
    PubMed     Text format     Abstract available


    Cancer Res

  10. CAPPARELLI C, Purwin TJ, Heilman SA, Chervoneva I, et al
    ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma.
    Cancer Res. 2018 Aug 16. pii: 0008-5472.CAN-18-1001.
    PubMed     Text format     Abstract available


    Eur J Dermatol

  11. BETTI R, Moneghini L, Vergani R, Cerri A, et al
    Diagnostic performance parameters for melanocytic lesions before and during the dermoscopy era.
    Eur J Dermatol. 2016.
    PubMed     Text format    


    Int J Cancer

  12. SHARBI-YUNGER A, Grees M, Gal C, Bassan D, et al
    A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.
    Int J Cancer. 2018 Aug 14. doi: 10.1002/ijc.31795.
    PubMed     Text format     Abstract available

  13. WU H, Larribere L, Sun Q, Novak D, et al
    Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.
    Int J Cancer. 2018 Aug 15. doi: 10.1002/ijc.31799.
    PubMed     Text format     Abstract available

  14. ZHAO B, Zhao H, Zhao J
    Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma.
    Int J Cancer. 2018 Aug 19. doi: 10.1002/ijc.31813.
    PubMed     Text format     Abstract available


    J Surg Oncol

  15. GONZALEZ AB, Baum CL, Brewer JD, Arpey CJ, et al
    Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins.
    J Surg Oncol. 2018 Aug 16. doi: 10.1002/jso.25176.
    PubMed     Text format     Abstract available

  16. HEWITT DB, Merkow RP, DeLancey JO, Wayne JD, et al
    National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
    J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25160.
    PubMed     Text format     Abstract available


    Lancet Oncol

  17. KRUSER TJ, Gondi V, Sperduto PW, Brown PD, et al
    Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.
    Lancet Oncol. 2018;19:e366.
    PubMed     Text format    

  18. LONG GV, Atkinson V, Hong A, McArthur GA, et al
    Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation - Authors' reply.
    Lancet Oncol. 2018;19:e367.
    PubMed     Text format    


    Melanoma Res

  19. HERBERT A, Koo MM, Barclay ME, Greenberg DC, et al
    Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data.
    Melanoma Res. 2018 Aug 13. doi: 10.1097/CMR.0000000000000489.
    PubMed     Text format     Abstract available

  20. ISAKOVIC AM, Petricevic SM, Ristic SM, Popadic DM, et al
    In vitro and in vivo antimelanoma effect of ethyl ester cyclohexyl analog of ethylenediamine dipropanoic acid.
    Melanoma Res. 2018;28:8-20.
    PubMed     Text format     Abstract available

  21. KENESSEY I, Kramer Z, Istvan L, Cserepes MT, et al
    Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model.
    Melanoma Res. 2018 Aug 17. doi: 10.1097/CMR.0000000000000488.
    PubMed     Text format     Abstract available

  22. EISENSTEIN A, Panova IP, Chung HJ, Goldberg LJ, et al
    Quantitative assessment of neuropilin-2 as a simple and sensitive diagnostic assay for spitzoid melanocytic lesions.
    Melanoma Res. 2018;28:71-75.
    PubMed     Text format     Abstract available


    Oncol Rep

  23. MOU K, Ding M, Han D, Zhou Y, et al
    miR5905p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.
    Oncol Rep. 2018;40:2056-2066.
    PubMed     Text format     Abstract available

  24. PENG Y, Jia L, Wang S, Cao W, et al
    Sonodynamic therapy improves antitumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.
    Oncol Rep. 2018;40:2163-2170.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: